David Shaw’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
David Shaw's BBIO Position: Q3 2026 in Review
David Shaw reduced its BridgeBio Pharma (BBIO) stake by 39% in Q3 2026, selling an estimated $110M and leaving 2,223,190 shares worth $146M. The position accounts for 0.07% of the portfolio, ranked #328.
David Shaw first reported a position in BBIO in Q1 2020 and has held it in 23 quarters since. The position peaked at $271M in Q2 2026. 466 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- David Shaw held 2,223,190 shares of BridgeBio Pharma worth $146M as of Q3 2026.
- David Shaw sold 1,409,817 BridgeBio Pharma shares in Q3 2026, an estimated $110M.
- BridgeBio Pharma made up 0.07% of David Shaw's portfolio in Q3 2026, its #328 holding.
- David Shaw first reported a position in BridgeBio Pharma in Q1 2020 and has held it in 23 quarters since.
- David Shaw's BridgeBio Pharma position peaked at $271M in Q2 2026.
- 466 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.